|
No. |
Topic |
Summary |
Pages |
10456
| GMP for Vaccine: What are the Issues? | - | 35 |
10457
| The Pecularities of Bacterial Vaccines | - | 40 |
10459
| Containment, Biological Safety and Product Protection | - | 58 |
10460
| Case Study: New Building of a multipurpose Vaccine Production Facility | - | 42 |
10461
| Decontamination of Rooms | - | 39 |
10464
| Case Study: GMP manufacturing of recombinant viral Vaccines for Clinical Trials | - | 37 |
10465
| cGMP Issues for Downstream Processing | - | 41 |
10466
| Cell Banks and Virus Seeds | - | 47 |
10467
| Biological Assays | - | 48 |
10468
| Case Study: Design, Construction and Qualification of a Pilot Vaccine Production Facility | - | 37 |
11141
| Issues of Staff Safety | - | 34 |
11548
| The Pecularities of Viral Vaccines | - | 30 |
11549
| cGMP Issues for Upstream Processing | - | 41 |
12494
| Decontamination, virus inactivation and virus removal techniques | - | 43 |
19-20 June 2013 